Study fails to support hair test in cancer diagnosis:
This article was originally published in Clinica
Executive Summary
A new study has failed to detect any difference between the X-ray scattering properties of hair from healthy women and women with breast cancer. Last year, Australian researchers reported that differences existed in the intermolecular structure of pubic hair from women with breast cancer, as revealed by X-ray diffraction analysis, although this finding was subsequently disputed by French researchers (see Clinica No 867, p 21). The latest study, which employed Bruker's benchtop Nanostar small-angle X-ray scattering system rather than synchrotron radiation, was performed by researchers in Germany and Austria and reported in the July 5 issue of the Journal of the National Cancer Institute.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.